fda glp-1 compounding crackdown news october 2025 cracks down on 'misleading' compounded GLP-1s by telehealth companies - Indianapolis | Indiana Weather | Indiana Traffic FDA proposes a new GLP-1

Light, P

Units and normalization procedures should be reported explicitly

While this research is still early, it may explain why some people develop diarrhea that persists beyond the typical 8 to 12 week adjustment window, and why probiotics have shown anecdotal benefit in managing GLP-1-related GI symptoms

For best results, pair disciplined budgeting with progressive learning: take notes, screenshot unusual boards, and revisit your strategy weekly

Those who qualify will be able to get drugs like Zepbound and Wegovy for $50 per month, far less than the current prices

Two oral GLP-1s have now received FDA approval: Novo Nordisks WEGOVY pill (December 2025) and Eli Lillys FOUNDAYO (April 2026)